Concepedia
Statistics
Publications
19
Citations
1.2K
H-Index
17
Active since
2003
Affiliations
Narodowy Instytut Leków(Current)
Temple University
Warsaw University of Technology
Medical University of Warsaw
RWTH Aachen University
Sylwia Flis is an author at Narodowy Instytut Leków specializing in oncology, medicine, and molecular oncology.
Publications per year
2003–2022
DNA methyltransferase inhibitors and their emerging role in epigenetic therapy of cancer.
Agnieszka Gnyszka, Zenon Jastrzębski, Sylwia Flis · PubMed · 2013 · 317 citations
Medicine, Oncology, Pharmacology +14
Rac2-MRC-cIII–generated ROS cause genomic instability in chronic myeloid leukemia stem cells and primitive progenitors
Margaret Nieborowska-Skorska, Piotr Kopiński, Regina Ray et al. · Blood · 2012 · 187 citations · Full text
Life Sciences, Genetics, Molecular Biology +12
Genomic instability may originate from imatinib-refractory chronic myeloid leukemia stem cells
Elisabeth Bolton-Gillespie, Mirle Schemionek, Hans‐Ulrich Klein et al. · Blood · 2013 · 132 citations · Full text
Medicine, Genetics, Molecular Genetics +12
Ruxolitinib-induced defects in DNA repair cause sensitivity to PARP inhibitors in myeloproliferative neoplasms
Margaret Nieborowska-Skorska, Silvia Maifrede, Yashodhara Dasgupta et al. · Blood · 2017 · 77 citations · Full text
Life Sciences, Molecular Biology, Oncology +17
DNA Methyltransferase Inhibitors Improve the Effect of Chemotherapeutic Agents in SW48 and HT-29 Colorectal Cancer Cells
Sylwia Flis, Agnieszka Gnyszka, Krzysztof Flis · PLoS ONE · 2014 · 53 citations · Full text
Medicine, Molecular Biology, Oncology +16
1–5 of 19